Glial Cell Line-Derived Neurotrophic Factor and Focal Ischemic Stroke
Authors:
- 16 February 2021
- journal article
- research article
- Published by Springer Nature in Neurochemical Research
- Vol. 46 (10) , 2638-2650
Abstract
Focal ischemic stroke (FIS) is a leading cause of human debilitation and death. Following the onset of a FIS, the brain experiences a series of spatiotemporal changes which are exemplified in different pathological processes. One prominent feature of FIS is the development of reactive astrogliosis and glial scar formation in the peri-infarct region (PIR). During the subacute phase, astrocytes in PIR are activated, referred to as reactive astrocytes (RAs), exhibit changes in morphology (hypotrophy), show an increased proliferation capacity, and altered gene expression profile, a phenomenon known as reactive astrogliosis. Subsequently, the morphology of RAs remains stable, and proliferation starts to decline together with the formation of glial scars. Reactive astrogliosis and glial scar formation eventually cause substantial tissue remodeling and changes in permanent structure around the PIR. Glial cell line-derived neurotrophic factor (GDNF) was originally isolated from a rat glioma cell-line and regarded as a potent survival neurotrophic factor. Under normal conditions, GDNF is expressed in neurons but is upregulated in RAs after FIS. This review briefly describes properties of GDNF, its receptor-mediated signaling pathways, as well as recent studies regarding the role of RAs-derived GDNF in neuronal protection and brain recovery. These results provide evidence suggesting an important role of RA-derived GDNF in intrinsic brain repair and recovery after FIS, and thus targeting GDNF in RAs may be effective for stroke therapy.Keywords
Funding Information
- National Institute of Neurological Disorders and Stroke (R01NS069726, R01NS094539)
- American Heart Association (16GRNT31280014, 16IRG27780023)
This publication has 156 references indexed in Scilit:
- Alternative splicing results in RET isoforms with distinct trafficking propertiesMolecular Biology of the Cell, 2012
- Development of a Method for the Purification and Culture of Rodent AstrocytesNeuron, 2011
- Heparan sulfate proteoglycan syndecan-3 is a novel receptor for GDNF, neurturin, and arteminJournal of Cell Biology, 2011
- Specific disruption of astrocytic Ca2+ signaling pathway in vivo by adeno-associated viral transductionNeuroscience, 2010
- Functions of Astrocytes and their Potential As Therapeutic TargetsNeurotherapeutics, 2010
- Cell Signaling by Receptor Tyrosine KinasesCell, 2010
- Origin and progeny of reactive gliosis: A source of multipotent cells in the injured brainProceedings of the National Academy of Sciences, 2008
- Glial cells as intrinsic components of non-cell-autonomous neurodegenerative diseaseNature Neuroscience, 2007
- GDNF reduces oxidative stress in a 6-hydroxydopamine model of Parkinson's diseaseNeuroscience Letters, 2007
- Intravenous administration of glial cell line‐derived neurotrophic factor gene‐modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult ratJournal of Neuroscience Research, 2006